M9241 (NHS-IL12)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M9241 (NHS-IL12), covering 2024-09-20 to 2024-09-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12) [Phase 1]